Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PrePaRad: Panitumumab and Radiotherapy in Rectal Cancer
NCT00973193Phase 2Terminated
- Start
- Sep 2009
- Primary completion
- Sep 2011
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of panitumumab in rectal cancer. Started Sep 2009; status: terminated.
02
Drugs
panitumumab
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT00973193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00973193.